Organized Corporate Crimes using Model Law Development for Health Regulation and Policy
Keywords:corporate governance, tax aggressiveness, corruption, fraud, off-Label medicines
Corporate Governance is a conceptual framework of business designs intended to illustrate the various activities of a company towards fulfilling its profit goals as private stakeholder and contributing to public interests for social obligation of sustainable development. Tax aggressiveness is utilized by board director and its members to lessen tax contribution which is contrary to the government sector goals of maximizing tax impositions for public welfare and safety. Unlawful behavior on tax aggressiveness is known as tax evasion while tax avoidance is not a violation and serves as a loophole to the taxation system, although corporate fraud is apparent in off-label medicines. UNCITRAL model law is a legal arbitration concept of making “commercial” expand to other comparable jurisdiction of international trade. The European Patent Commission is the legal authority that delineates medical policies from patented products. This paper aims to develop arbitration framework based on stakeholder theory of corporate governance to separate tax evasion from tax avoidance as crime sourcing treatment of policies and engineer tax planning to divide intellectual property of product design with corporate fraud concerning off-label medicines. Therefore, organized crimes in pharmaceutical industries are needed to be clearly managed by institutional healthcare companies for promoting economic success.
Dias, A., Rodrigues, L.L. & Craig, R. (2017). Corporate Governance Effects on Social Responsibility Disclosures. Australasian Accounting, Business and Finance Journal, 11(2).
Gouda, G.M. & Sharma, R. (2018). A Study of Corporate Governance and Social Responsibility. International Journal of Advance Research and Innovative Ideas in Education, 4(1).
Handayani, R. (2019). Analysis of Corporate Social Responsibility and Good Corporate Governance to Tax Aggressiveness. International Journal of Academic Research in Accounting, Finance and Management Sciences, 9(3).
Hidy, K. & Diener, K.W. (2020). Damages under CISG: Attorneys’ Fees and other Losses in International Commercial Law. Journal of Transnational Law and Policy, 29(1).
Hoellering, M. (1986). The UNCITRAL Model Law on International Commercial Arbitration. The International Lawyer, 20(1).
Huynh, Q.L. (2020). A Triple of Corporate Governance, Social Responsibility and Earnings Management. Journal of Asian Finance, Economics and Business, 7(3).
Mackey, T. & Liang, B. (2012). Combating healthcare corruption and fraud with improved global health governance. BMC International Health and Human Rights, 12(23).
Mantilla-Serrano, F. & Adam, J. (2008). UNCITRAL Model Law: Missed Opportunities for Enhanced Uniformity. UNSW Law Journal, 31(1).
Mulinari, S., Davis, C. & Ozieranski, P. (2021). Failure of Responsive Regulation? Pharmnaceutical Marketing, Corporate Impression Management and Off-Label Promotion of Enzalutamide in Europe. Journal of White Collar and Corporate Crime, 2(2).
Myint, U. (2000). Corruption: Causes, Consequenquences, and Cures. Asia-Pacific Development Journal, 7(2).
Obaretin, O. & Ogbeide, S.O. (2018). Corporate Governance Mechanisms and Tax Aggressiveness of Listed Firms in Nigeria. Amity Journal of Corporate Governance, 3(1).
O’Keefe, R. (2010). Protection of Cultural Property under International Criminal Law. Melbourne Journal of International Law, 11(2).
Repucci, N. (2011). An Examination of Off-Label Marketing and Promotion: Settlements, Issues, and Trends. Journal of Healthcare Compliance, September-October, 15-21.
Salhi, B., Al Jabr, J. & Jarboui, A. (2020). A Comparison of Corporate Governance and Tax Avoidance of UK and Japanese Firms. Comparative Economic Research, 23(3).
Sanson, M. (2016). Statutory Interpretation, 2nd edition, Oxford University Publishing.
Ventose, E. (2009). Patent Protection for Second and Further Medical Uses Under the European Patent Convention. SCRIPTed, 6(1).
Widiatmoko, J. (2020). Corporate Governance Mechanism and Corporate Social Responsibility on Firm Value. Relevance: Journal of Management and Business, 3(1).